The University of Medicine and Pharmacy "Iuliu Hatieganu" in Cluj-Napoca, Romania, is seeking suppliers for a laboratory imaging system specifically designed for the analysis of Western Blot gels. This procurement opportunity is valued at €103,300 and aims to enhance laboratory capabilities in analy
Contract awarded. Originally published 8 months ago.
Only 1 prior award here — too little to read.
In research innovation, IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY CLUJNAPOCA has awarded 1 contract to 1 supplier.
Across research innovation, the most active winners are WOLF LABORATORIES LIMITED, MV CORPORATION EOOD, ALTIUM INTERNATIONAL SRO — the field to beat, or your route in as a partner.
The University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj-Napoca is seeking suppliers for laboratory reagents and consumables across 13 different categories to support research activities in the project titled "Development of Translational Research for Vaccines, Serums, and Other Biological Med
This contract opportunity involves providing high-sensitivity proteomic analysis services using dual recognition technologies and next-generation DNA sequencing (PEA or equivalent). The services are required for analyzing 86 samples collected from patients with thyroid cancer. Suppliers are expected
This contract is for high-sensitivity proteomic analysis services using dual recognition technologies and next-generation DNA sequencing (PEA or equivalent). The services will involve analyzing 172 samples collected from lung cancer patients. Suppliers are invited to provide these specialized servic
The University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj-Napoca is seeking high-performance laptops for conducting bioinformatics analyses as part of the research project PNRR 760067. The laptops must meet specific technical requirements outlined in the specifications document. This opportunit
Funding up to £3 million for human experimental medicine studies investigating the biological and psychological causes of gambling disorder development and recovery.
Apply for up to £26.25 million in MRC funding over 14 years to establish a centre of research excellence addressing complex health challenges.
Grants up to £200,000 available for early-stage, high-risk environmental research projects without requiring preliminary data, running for up to two years.
UKRI is funding empirical research to establish reliable estimates of the economic and social returns on R&D investments to guide public and private sector decision-making.
